The Metformin for Abdominal Aortic Aneurysm Growth Inhibition (MAAAGI) Trial

Eur J Vasc Endovasc Surg. 2021 Apr;61(4):710-711. doi: 10.1016/j.ejvs.2020.11.048. Epub 2021 Jan 27.

MAAAGI Trial Investigators:
Karl W Olsson², Martin Björck², Dick Wågsäter⁴, Tomas Hansen⁵, Lars Karlsson⁶, Birgitta Sigvant⁷, Sverker Svensjö⁸, Mari Holsti⁹, Sven-Erik Persson⁹, Moncef Zarrouk³, Leena Lehti³, Björn Sonesson³

¹ Department of Surgical Sciences, Vascular Surgery, Uppsala University, Uppsala, Sweden; Department of Surgical and Peri-operative Sciences, Umeå University, Umeå, Sweden. Electronic address: anders.wanhainen@surgsci.uu.se.
² Department of Surgical Sciences, Vascular Surgery, Uppsala University, Uppsala, Sweden.
³ Department of Vascular Diseases, Skåne University Hospital and Lund University, Malmö, Sweden.
⁴ Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
⁵ Department of Surgical Sciences, Radiology, Uppsala University, Uppsala, Sweden.
⁶ Department of Surgical Sciences, Vascular Surgery, Uppsala University, Uppsala, Sweden; Department of Surgery, Gävle Hospital, Gävle, Sweden.
⁷ Department of Surgical Sciences, Vascular Surgery, Uppsala University, Uppsala, Sweden; Department of Vascular Surgery, Central Hospital, Karlstad, Sweden.
⁸ Department of Surgical Sciences, Vascular Surgery, Uppsala University, Uppsala, Sweden; Centre for Clinical Research, Uppsala University, Region Dalarna, Falun, Sweden; Department of Surgery, Falun Hospital, Sweden.
⁹ Department of Surgical and Peri-operative Sciences, Umeå University, Umeå, Sweden.

No abstract available

Publication types